A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer
Phase 3
- Conditions
- Bladder Cancer
- Registration Number
- NCT02951078
- Lead Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Brief Summary
This study is to verify the short-term efficacy and long-term prognosis of thulium laser resection compared with conventional transurethral resection of non-muscular invasive bladder cancer. Half of participants will receive thulium laser resection of bladder cancer, while the other half will receive electrical transurethral resection of bladder cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- 172
Inclusion Criteria
- Pathological or histological diagnosis of primary non-muscle invasive bladder urothelial carcinoma (TaTisT1);
- Imaging examinations showed the bladder muscle has not been affected, no lymph node metastasis or distant metastasis;
- Patients who agree to TURBT surgery, and will be effected to the postoperative follow-up treatment such as conventional infusion after the operation;
- Function of main organs (heart, liver, lung, kidney) should be normal, PS score 0-2;
- Bladder capacity≥ 200ml.
Exclusion Criteria
- Find distant metastasis ,infiltration of the surrounding organs or relapse before operation.Metastatic bladder cancer or other cancers involve the bladder;
- Received chemotherapy or BCG perfusion therapy in the nearly 3 months;
- Patients who can not tolerate the serious side effects during the bladder perfusion treatment process (bladder irritation and other symptoms);
- Patients during pregnancy ,critical care patients and patients who have other cases of surgical contraindications.Such as serious cardiovascular disease,coagulation abnormalities,non-transitional epithelial tumors( such as adenocarcinoma and squamous cell carcinoma),acute cystitis,can not be supine because of spinal deformity,untreated urethral stricture.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method The residual rate of tumor in the second operation of the two surgical methods 2 years
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms differentiate thulium laser resection from electrical transurethral resection in non-muscle invasive bladder cancer?
How does thulium laser en bloc resection compare to standard electrical TURBT in recurrence rates and bladder preservation outcomes for NMIBC patients?
Are there specific urothelial biomarkers that predict better response to thulium laser resection over conventional TUR in non-muscular invasive bladder tumors?
What are the adverse event profiles and management strategies for thulium laser versus electrical transurethral resection in bladder cancer treatment?
What combination therapies or alternative laser technologies show promise alongside thulium laser resection for non-muscle invasive bladder cancer management?